Nassiba Menghoum

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Heart failure with preserved ejection fraction shows no excess mortality in older patients: a population-matched relative survival analysis.

Heart failure with preserved ejection fraction shows no excess mortality in older patients: a population-matched relative survival analysis.

Journal: GeroScience
Published: September 05, 2025

Placental Angiogenic Imbalance and Its Association With Adverse Outcomes in Congenital Heart Disease Pregnancies.

Placental Angiogenic Imbalance and Its Association With Adverse Outcomes in Congenital Heart Disease Pregnancies.

Journal: JACC. Advances
Published: July 02, 2025

Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction.

Exploring the impact of metabolic comorbidities on epicardial adipose tissue in heart failure with preserved ejection fraction.

Journal: Cardiovascular diabetology
Published: November 17, 2024

Characteristics of patients requesting an abortion beyond 14 weeks of gestation: Retrospective study in Brussels.

Characteristics of patients requesting an abortion beyond 14 weeks of gestation: Retrospective study in Brussels.

Journal: Contraception
Published: January 04, 2024

Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project.

Plasma myo-inositol elevation in heart failure: clinical implications and prognostic significance. Results from the BElgian and CAnadian MEtabolomics in HFpEF (BECAME-HF) research project.

Journal: EBioMedicine
Published: November 29, 2023

Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction.

Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction.

Journal: ESC heart failure
Published: September 16, 2023

Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients.

Dual antiplatelet therapy is associated with high α-tubulin acetylation in circulating platelets from coronary artery disease patients.

Journal: Platelets
Published: September 12, 2023

Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction.

Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction.

Journal: Platelets
Published: May 09, 2023

How to evaluate cardiomyopathies by cardiovascular magnetic resonance parametric mapping and late gadolinium enhancement.

How to evaluate cardiomyopathies by cardiovascular magnetic resonance parametric mapping and late gadolinium enhancement.

Journal: European heart journal. Cardiovascular Imaging
Published: January 18, 2022

Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period.

Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated with SGLT2 inhibitors: A review of 72 cases over a 4.5-year period.

Journal: Diabetes & metabolic syndrome
Published: March 07, 2021

Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases

Diabetic euglycemic ketosis or ketoacidosis in individuals with type 2 diabetes treated by SGLT2 inhibitors: A series of Belgian clinical cases

Journal: La Revue de medecine interne
Published: August 16, 2019
Showing 1-11 of 11

Last Updated: 09/26/2026